Developer of non-surgical intervention device designed to treat chronic rhinitis safely. The company specializes in minimally invasive hand-held radio-frequency devices that are introduced through the nostrils into the nasal cavity under direct endoscopic visualization where it deploys a microelectrode array that delivers targeted energy to interrupt the autonomic function within the mucosal structures of nasal cavities which will reverse the inflammatory cascade, enabling surgeons to treat patients in an office setting, removing the complications and costs associated with most surgical procedures.
Developer of a healthcare technology designed to clear nasal congestion in babies and children. The company provides painkillers in nasal aspiration for hospital-grade suction, a patented two-finger nosepiece allowing parents the ease of treatment at home and helps with better sleep, eating, and breathing through respiratory, air, and humidity products, enabling babies to breathe, eat, and sleep and allowing families to take care of congested children at home instead of at the hospital.
Developer of non-invasive neurostimulation products designed to treat global health epidemics. The company's medical device technology offers transdermal activation of the homeostatic nuclei of the brainstem and hypothalamus to allow for alterations in autonomic function, circadian regulation, and neuro-metabolic influence, enabling healthcare providers to provide drug-free options and improve patients' health outcomes.
Developer of electroceuticals designed to address prevalent neurological pain diseases. The company's product offers an innovative FDA-authorized, non-invasive, smartphone-operated, prescribed wearable, use-and-dispose, and provides temporary or long-term pain relief, enabling patients to treat acute migraines affordably.